These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 21893349)
1. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349 [TBL] [Abstract][Full Text] [Related]
2. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895 [TBL] [Abstract][Full Text] [Related]
3. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Epperson CN; Jatlow PI; Czarkowski K; Anderson GM Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087 [TBL] [Abstract][Full Text] [Related]
4. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Maurer-Spurej E; Pittendreigh C; Solomons K Thromb Haemost; 2004 Jan; 91(1):119-28. PubMed ID: 14691577 [TBL] [Abstract][Full Text] [Related]
5. Bioprofiling of platelets in medicated patients with depression. Hüfner K; Kandler C; Koudouovoh-Tripp P; Egeter J; Hochstrasser T; Stemer B; Malik P; Giesinger J; Humpel C; Sperner-Unterweger B J Affect Disord; 2015 Feb; 172():81-8. PubMed ID: 25451399 [TBL] [Abstract][Full Text] [Related]
6. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial. Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940 [TBL] [Abstract][Full Text] [Related]
7. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation. Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601 [TBL] [Abstract][Full Text] [Related]
8. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects? Hoirisch-Clapauch S; Nardi AE; Gris JC; Brenner B Thromb Res; 2014 Jul; 134(1):11-6. PubMed ID: 24661990 [TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors: measurement of effect on platelet function. McCloskey DJ; Postolache TT; Vittone BJ; Nghiem KL; Monsale JL; Wesley RA; Rick ME Transl Res; 2008 Mar; 151(3):168-72. PubMed ID: 18279816 [TBL] [Abstract][Full Text] [Related]
10. Plasma serotonin levels are associated with antidepressant response to SSRIs. Holck A; Wolkowitz OM; Mellon SH; Reus VI; Nelson JC; Westrin Å; Lindqvist D J Affect Disord; 2019 May; 250():65-70. PubMed ID: 30831543 [TBL] [Abstract][Full Text] [Related]
11. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090 [TBL] [Abstract][Full Text] [Related]
12. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants. Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259 [TBL] [Abstract][Full Text] [Related]
13. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Berger JS; Becker RC; Kuhn C; Helms MJ; Ortel TL; Williams R Thromb Haemost; 2013 Jan; 109(1):85-92. PubMed ID: 23223800 [TBL] [Abstract][Full Text] [Related]
17. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Serebruany VL; Gurbel PA; O'Connor CM Pharmacol Res; 2001 May; 43(5):453-62. PubMed ID: 11394937 [TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation. Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430 [TBL] [Abstract][Full Text] [Related]
19. Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction? Schlienger RG; Meier CR Am J Cardiovasc Drugs; 2003; 3(3):149-62. PubMed ID: 14727927 [TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors and endothelial function in women. Hantsoo L; Czarkowski KA; Child J; Howes C; Epperson CN J Womens Health (Larchmt); 2014 Jul; 23(7):613-8. PubMed ID: 24886268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]